"Multiplexing technology for in vitro diagnosis of pathogens: the key contribution of phosphorus dendrimers” by Jean Pierre Majoral View publication
Since February 2018, Dendris has tested its device on two news partner pilot site, Gen-Bio Gravanches, in Clermont Ferrand and Biolab avenir in Toulouse.
RICAI is a well known congress dedicated to infectious diseases. Dendris will present its molecular diagnosis devices on december 2018 17th and 18th at the palais des congress in Paris. http://www.ricai.fr
Dendris team wishes you a happy new year 2018 !
RICAI is a well known congress dedicated to infectious diseases. Dendris presented its molecular diagnosis devices. We presented a poster titled : "Diagnostic syndromique des infections respiratoires" Alice Senescau-Lemoine, Tatiana Kemposky-Hamon, Elodie Bernard,...
Dendris has obtained quality management system certificate ISO 13485:2016 in November 2017 for design, development, manufacturing and distribution of in-vitro diagnostic test kits used in the diagnosis of respiratory infections.
During the year 2017, Dendris tested its device on two partner pilot sites. A third site is planned for installation in February 2018 as well as two other current 2018
This conference organised by Occitanie Region was dedicated to biomarkers. Several speakers (researchers, clinicans and industrials) presented their studies and projects in biomarker field. Dendri has presented its know how in designing biomarkers dedicated to...
This conference organised by CCI Occitanie gathered authorities and industrials acting in Medical Device field. Dendris has been invited to give its feed back on EC regulation impact for a start up.
This event dedicated to start up acting in Medical Device field took place in Institut Pasteur site in Paris. An opportunity to Dendris to present its solution and get in touch with potential partners.